Literature DB >> 6134299

Effects of three dopamine agonists on cage climbing behavior.

G Gianutsos, J L Palmeri.   

Abstract

The effects of three structurally related dopamine (DA) agonists (pergolide, lergotrile, bromocriptine) on motor activity and induction of cage climbing behavior were compared in mice. Pergolide stimulated activity and induced cage climbing that persisted for at least 5 h. Lergotrile depressed activity and failed to induce climbing over a wide range of doses. Bromocriptine produced stimulation and climbing, but only after a 2-3 h delay following injection. The qualitative differences among these drugs may represent an action involving different DA receptor subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134299     DOI: 10.1007/bf00433412

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.

Authors:  P F Vonvoigtlander; E G Losey; H J Triezenberg
Journal:  J Pharmacol Exp Ther       Date:  1975-04       Impact factor: 4.030

3.  Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.

Authors:  A R Cools; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1976-02-02

4.  Effects of bromocriptine on central dopaminergic receptors.

Authors:  M Trabucchi; P F Spano; G C Tonon; L Frattola
Journal:  Life Sci       Date:  1976-07-15       Impact factor: 5.037

5.  The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists.

Authors:  E K Silbergeld; H Adler; S Kennedy; D B Calne
Journal:  J Pharm Pharmacol       Date:  1977-10       Impact factor: 3.765

6.  Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats.

Authors:  R W Fuller; J A Clemens; E C Kornfeld; H D Snoddy; E B Smalstig; N J Bach
Journal:  Life Sci       Date:  1979-01-22       Impact factor: 5.037

7.  Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.

Authors:  B Costall; R J Naylor; V Nohria
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

8.  A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.

Authors:  J E Thornburg; K E Moore
Journal:  Neuropharmacology       Date:  1974-03       Impact factor: 5.250

9.  Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Authors:  R J Baldessarini; N S Kula; K G Walton
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

10.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

View more
  4 in total

1.  Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.

Authors:  M R Zarrindast; K Shahed-Dirin
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine.

Authors:  A S Davis; P Jenner; C D Marsden
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  Production of climbing behaviour in mice requires both D1 and D2 receptor activation.

Authors:  N A Moore; M S Axton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.

Authors:  A Davis; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.